Edwards Lifesciences initiated with a Neutral at UBS. UBS analyst Matthew Taylor initiated Edwards Lifesciences with a Neutral rating and $165 price target. https://thefly.com/landingPageNews.php?id=2828785
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.